Successful treatment of nephrotic syndrome due to systemic AL amyloidosis after autologous stem cell transplantation: renal response is an important therapeutic end point.

Akay, O M; Sahin, G; Kabukcuoglu, S; Yalcin, A U; Gulbas, Z

Akay, O M; Sahin, G; Kabukcuoglu, S; Yalcin, A U; Gulbas, Z.

Affiliation

Akay OM; Department of Hematology, Eskisehir Osmangazi University Medical Faculty, Eskisehir, Turkey. melhak@hotmail.com

Clin Nephrol ; 69(4): 294-7, 2008 Apr.

Article in En | MEDLINE | ID: mdl-18397705

Subject(s)

Amyloidosis/complications; Amyloidosis/therapy; Nephrotic Syndrome/etiology; Nephrotic Syndrome/therapy; Peripheral Blood Stem Cell Transplantation; Amyloidosis/pathology; Humans; Male; Middle Aged; Nephrotic Syndrome/pathology; Transplantation, Autologous; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Peripheral Blood Stem Cell Transplantation / Amyloidosis / Nephrotic Syndrome Type of study: Prognostic_studies Limits: Humans / Male / Middle aged Language: En Journal: Clin Nephrol Year: 2008 Type: Article Affiliation country: Turkey

Search on Google

XML

PubMed Links